AfroCentric Investment Corporation Limited (JSE:ACT)

South Africa flag South Africa · Delayed Price · Currency is ZAR · Price in ZAc
90.00
-4.00 (-4.44%)
Mar 11, 2026, 4:46 PM SAST
Market Cap736.77M -48.0%
Revenue (ttm)7.46B -15.7%
Net Income-1.27B
EPS-1.52
Shares Out818.63M
PE Ration/a
Forward PEn/a
Dividend0.12 (12.77%)
Ex-Dividend DateMay 7, 2025
Volume15,351
Average Volume73,602
Open85.00
Previous Close90.00
Day's Range85.00 - 90.00
52-Week Range80.00 - 188.00
Beta-0.00
RSI35.41
Earnings DateMar 2, 2026

About JSE:ACT

AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers HIV and other healthcare management solutions. The company engages in the retail and wholesale of pharmaceutical products under the Activo Health, AfroCentric Technologies, AfA, Allegra, Denis, EssentialMED, Klinikka, Medscheme, Pharmacy Direct, Sc... [Read more]

Sector Healthcare
Founded 2008
Employees 5,503
Stock Exchange Johannesburg Stock Exchange
Ticker Symbol ACT
Full Company Profile

Financial Performance

In 2025, JSE:ACT's revenue was 7.51 billion, a decrease of -12.59% compared to the previous year's 8.60 billion. Losses were -1.27 billion, 406.2% more than in 2024.

Financial Statements